CHRISTOPHER BAKER: Open Payments
NPI 1356529465 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 17 payments from 8 companies in 2025. Trend: 2023 $199 · 2024 $368 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| DePuy Synthes Sales Inc. | 3 | $252 |
| AstraZeneca Pharmaceuticals LP | 6 | $186 |
| Astellas Pharma US Inc | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Exact Sciences Corporation | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: NA, BREZTRI, AIRSUPRA, Veozah, Kerendia, FARXIGA, The Cologuard Plus Collection Kit, PREVNAR 20.
Industry payments across MD — which companies pay providers there.
